Biosergen AB (publ) (STO:BIOSGN)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.350
-0.020 (-1.46%)
Sep 4, 2026, 2:06 PM CET

Biosergen AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-32.32-38.01-19.2-27.04-34.05-41.18
Other Operating Activities
00----0
Change in Accounts Receivable
-1.53-2.052.91-0.870.02-
Change in Accounts Payable
----5.110.061.96
Change in Other Net Operating Assets
2.383.256.110.424.52-6.07
Operating Cash Flow
-31.46-36.81-10.18-32.6-29.44-45.3
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
--58.915.1437.1270.59
Repurchase of Common Stock
-0.04-0.04----
Financing Cash Flow
-0.04-0.0458.915.1437.1270.59

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.471.6----
Net Cash Flow
-30.03-35.2548.73-27.467.6825.29

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-18.38-22.58-9.41-23.83-16.25-
Unlevered Free Cash Flow
-18.37-22.57-9.36-23.82-16.21-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
000.080.010.05-
Change in Working Capital
0.851.29.02-5.574.61-4.12